Literature DB >> 8730749

The effects of saponin on the binding and functional properties of the human adenosine A1 receptor.

F R Cohen1, S Lazareno, N J Birdsall.   

Abstract

1. Experiments with adenosine deaminase suggest that adenosine is present in membrane preparations from CHO cells bearing adenosine A1 receptors. 2. Pretreatment of the membranes (ca 0.6 mg protein ml-1) with the permeabilizing agent saponin (100 micrograms ml-1) or addition of saponin (10 micrograms ml-1) to the membranes (0.02-0.08 mg protein ml-1) in the assay, generates homogeneous low affinity agonist binding curves in the presence of GTP and an increased function, assessed by agonist stimulation of [35S]-GTP gamma S binding. The affinity constants for the binding of an agonist and an antagonist are not affected by this saponin treatment. Saponin facilitates the interaction of guanine nucleotides with receptor G-protein complexes, possibly by removing a permeability barrier to access of G-proteins by GTP. However, adenosine is still present in the binding assays after saponin treatment. 3. The agonist binding properties of the human A1 receptor have been characterized. In saponin pretreated membranes, 80-90% of the A1 receptors are capable of forming agonist-receptor-G protein complexes in the absence of GTP. These complexes have a 300-600 fold higher affinity than uncoupled receptors for N6-cyclohexyladenosine. 4. A very slow component is observed in the association and dissociation kinetics of the agonist [3H]-N6-cyclohexyladenosine ([3H]-CHA) and in the association but not dissociation kinetics of the antagonist [3H]-8-cyclopentyl-1,3-dipropylxanthine ([3H]-DPCPX). The slow association component of [3H]-DPCPX is essentially absent when incubations are carried out in the presence of GTP. The slow dissociation component of [3H]-CHA binding is rapidly disrupted by GTP. 5. It is hypothesized that long-lasting adenosine-receptor-G protein complexes are present in the CHO membrane preparations. The existence of these complexes, resistant to the action of adenosine deaminase but sensitive to GTP, may rationalize the observed kinetics and the increase in 3H-antagonist binding produced by GTP which has been observed in essentially all studies of A1 receptors and has been ascribed previously to precoupling of A1 receptors to G-proteins in the absence of agonists.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8730749      PMCID: PMC1909466          DOI: 10.1111/j.1476-5381.1996.tb15316.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

Review 1.  Adenosine deaminase for removing adenosine: how much is enough?

Authors:  J Linden
Journal:  Trends Pharmacol Sci       Date:  1989-07       Impact factor: 14.819

2.  Differential permeabilization of membranes by saponin treatment of isolated rat hepatocytes. Release of secretory proteins.

Authors:  M Wassler; I Jonasson; R Persson; E Fries
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

3.  Ultrastructural antibody localization of alpha2-macroglobulin in membrane-limited vesicles in cultured cells.

Authors:  M C Willingham; S S Yamada; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

4.  Characterization of two affinity states of adenosine A2a receptors with a new radioligand, 2-[2-(4-amino-3-[125I]iodophenyl)ethylamino]adenosine.

Authors:  D R Luthin; R A Olsson; R D Thompson; D R Sawmiller; J Linden
Journal:  Mol Pharmacol       Date:  1995-02       Impact factor: 4.436

5.  A1 adenosine receptor-G protein coupling in bovine brain membranes: effects of guanine nucleotides, salt, and solubilization.

Authors:  G L Stiles
Journal:  J Neurochem       Date:  1988-11       Impact factor: 5.372

6.  Shallow agonist competition binding curves for beta-adrenergic receptors: the role of tight agonist binding.

Authors:  Y Severne; A Ijzerman; V Nerme; H Timmerman; G Vauquelin
Journal:  Mol Pharmacol       Date:  1987-01       Impact factor: 4.436

7.  Assessment of mechanistic proposals for the binding of agonists to cardiac muscarinic receptors.

Authors:  H M Wong; M J Sole; J W Wells
Journal:  Biochemistry       Date:  1986-11-04       Impact factor: 3.162

8.  Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4.

Authors:  S Lazareno; T Farries; N J Birdsall
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

9.  Calcium pools in saponin-permeabilized guinea pig hepatocytes.

Authors:  G M Burgess; J S McKinney; A Fabiato; B A Leslie; J W Putney
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

10.  Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.

Authors:  H Matsui; S Lazareno; N J Birdsall
Journal:  Mol Pharmacol       Date:  1995-01       Impact factor: 4.436

View more
  8 in total

Review 1.  Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors.

Authors:  Philip G Strange
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  The effect of allosteric modulators on the kinetics of agonist-G protein-coupled receptor interactions in single living cells.

Authors:  Lauren T May; Tim J Self; Stephen J Briddon; Stephen J Hill
Journal:  Mol Pharmacol       Date:  2010-06-22       Impact factor: 4.436

3.  Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors.

Authors:  C Browning; I Beresford; N Fraser; H Giles
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

4.  Effects of urea pretreatment on the binding properties of adenosine A1 receptors.

Authors:  Lauren T May; Patrick M Sexton; Arthur Christopoulos
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

5.  SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor.

Authors:  M E Bradley; M E Bond; J Manini; Z Brown; S J Charlton
Journal:  Br J Pharmacol       Date:  2009-04-24       Impact factor: 8.739

6.  New selective ligands of human cloned melatonin MT1 and MT2 receptors.

Authors:  Valérie Audinot; François Mailliet; Chantal Lahaye-Brasseur; Anne Bonnaud; Aude Le Gall; Christophe Amossé; Sandra Dromaint; Marianne Rodriguez; Nadine Nagel; Jean-Pierre Galizzi; Benoît Malpaux; Gérald Guillaumet; Daniel Lesieur; François Lefoulon; Pierre Renard; Philippe Delagrange; Jean A Boutin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-23       Impact factor: 3.000

7.  Paris saponin H inhibits the proliferation of glioma cells through the A1 and A3 adenosine receptor‑mediated pathway.

Authors:  Linlin Bi; Yang Liu; Qian Yang; Xuanxuan Zhou; Hua Li; Yang Liu; Jie Li; Yunyang Lu; Haifeng Tang
Journal:  Int J Mol Med       Date:  2021-02-04       Impact factor: 4.101

8.  A two-state model for the kinetics of competitive radioligand binding.

Authors:  Dong Guo; Lambertus A Peletier; Lloyd Bridge; Wesley Keur; Henk de Vries; Annelien Zweemer; Laura H Heitman; Adriaan P IJzerman
Journal:  Br J Pharmacol       Date:  2018-04-17       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.